Cramer's Lightning Round - Qualcomm Is Finally Getting Respect (11/13/12)
11/14/2012 5:42:00 AM - Seeking Alpha
Biotech Catalyst Calendar - 4 Stocks To Watch In November
11/7/2012 8:59:00 AM - Seeking Alpha
3 November Catalysts For Biotech Traders
11/6/2012 5:05:00 AM - Seeking Alpha
Exelixis Stock Treads Water Ahead Of FDA Decision
10/26/2012 3:07:00 PM - Seeking Alpha
3 Companies With Promising New Cancer Treatments
10/23/2012 9:35:00 AM - Seeking Alpha
ArQule's Tivantinib Failure And Exelixis' Cabozantinib PDUFA: Is There A Correlation?
10/12/2012 9:10:00 AM - Seeking Alpha
Winners Of ESMO 2012
10/8/2012 6:07:00 PM - Seeking Alpha
Exelixis: First Partnered Program Enters Phase III
10/3/2012 8:25:00 AM - Seeking Alpha
As ArQule Investors Panic, Watch Exelixis Too
10/3/2012 8:19:00 AM - Seeking Alpha
3 Sub $10 Heavily Shorted High Volume Small Cap Biotechs Rated Buy With Momentum
9/20/2012 10:21:00 AM - Seeking Alpha
4 Biotech Stocks Ready to Explode
9/6/2012 1:30:00 PM - David Sterman
After Hours Most Active for Sep 4, 2012 : LYB, HT, SHLD, QQQ, KGC, MTL, CVH, BAC, EXEL, MSFT, FB, FRAN
9/4/2012 4:44:58 PM - NASDAQ.com News
After Hours Most Active for Aug 31, 2012 : QQQ, MO, ARR, MRK, BAC, CTL, EXEL, NIHD, ESV, INTC, SIRI, ARNA
8/31/2012 4:44:46 PM - NASDAQ.com News
Pre-Market Most Active for Aug 9, 2012 : EXEL, RBN, NOK, BAC, CSCO, ALLY^A, SIRI, AHL, QQQ, WIN, SPH, MNST
8/9/2012 8:39:59 AM - NASDAQ.com News
Noteworthy Institutional 5% Ownership Filings This Week In Healthcare And Tech
3/15/2012 5:42:00 PM - Seeking Alpha
Large, Diverse Pipelines At Small Biotech Companies
3/13/2012 2:30:00 PM - Seeking Alpha
5 Overlooked Healthcare Stocks To Consider Now
2/18/2012 6:22:00 PM - Seeking Alpha
5 Promising But Risky Biotechs With Long-Term Potential
2/10/2012 12:15:00 PM - Seeking Alpha
Big, Robust Pipelines At Small Biotech Companies
2/7/2012 3:10:00 PM - Seeking Alpha
Biotech Stocks To Watch In 2012
2/6/2012 9:26:00 AM - Seeking Alpha
5 Biotech Stocks That Could Double
2/1/2012 7:44:00 AM - Seeking Alpha
7 Best-Performing, Heavily Traded Biotechs Of The Year Under $10
1/30/2012 10:58:00 AM - Seeking Alpha
All Objectives Met In The $50k Challenge: 10.3% Return In Less Than 5 Days
1/15/2012 4:50:00 AM - Seeking Alpha
Celldex Therapeutics: A Potential Triple With Data On The Way
1/10/2012 11:57:00 PM - Seeking Alpha
Circumstances That Encourage Selecting Specific Biotech Stocks
1/10/2012 11:03:00 AM - Seeking Alpha